PURPOSE: Vertebral body defects represent one of the most common orthopedic challenges. In order to advance the transfer of stem cell therapies into orthopedic clinical practice, we performed this study to evaluate the safety and efficacy of a composite bioartificial graft based on a hydroxyapatite bone scaffold (CEM-OSTETIC(®)) combined with human mesenchymal stem cells (MSCs) in a rat model of vertebral body defects. METHODS: Under general isoflurane anesthesia, a defect in the body of the L2 vertebra was prepared and left to heal spontaneously (group 1), implanted with scaffold material alone (group 2), or implanted with a scaffold together with 0.5 million MSCs (group 3) or 5 million MSCs (group 4). The rats were killed 8 weeks after surgery. Histological and histomorphometrical evaluation of the implant as well as micro-CT imaging of the vertebrae were performed. RESULTS: We observed a significant effect on the formation of new bone tissue in the defect in group 4 when compared to the other groups and a reduced inflammatory reaction in both groups receiving a scaffold and MSCs. We did not detect any substantial pathological changes or tumor formation after graft implantation. CONCLUSIONS: MSCs in combination with a hydroxyapatite scaffold improved the repair of a model bone defect and might represent a safe and effective alternative in the treatment of vertebral bone defects.

Institute of Experimental Medicine Academy of Sciences of the Czech Republic Vídeňská 1083 142 20 Prague 4 Czech Republic

See more in PubMed

Barsa P. Vertebroplasty—treatment options for structurally insufficient vertebras. Cesk Slov Neurol N. 2012;75:8–17.

Sedy J, Urdzikova L, Jendelova P, Sykova E. Methods for behavioral testing of spinal cord injured rats. Neurosci Biobehav Rev. 2008;32:550–580. doi: 10.1016/j.neubiorev.2007.10.001. PubMed DOI

Sykova E, Homola A, Mazanec R, Lachmann H, Konradova SL, Kobylka P, Padr R, Neuwirth J, Komrska V, Vavra V, Stulik J, Bojar M. Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transpl. 2006;15:675–687. doi: 10.3727/000000006783464381. PubMed DOI

Wang Z, Lu B, Chen L, Chang J. Evaluation of an osteostimulative putty in the sheep spine. J Mater Sci Mater Med. 2011;22:185–191. doi: 10.1007/s10856-010-4175-5. PubMed DOI

Bauer TW, Muschler GF (2000) Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 371:10–27 PubMed

Niu X, Feng Q, Wang M, Guo X, Zheng Q. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release. 2009;134:111–117. doi: 10.1016/j.jconrel.2008.11.020. PubMed DOI

Srouji S, Rachmiel A, Blumenfeld I, Livne E. Mandibular defect repair by TGF-beta and IGF-1 released from a biodegradable osteoconductive hydrogel. J Craniomaxillofac Surg. 2005;33:79–84. doi: 10.1016/j.jcms.2004.09.003. PubMed DOI

Zhang M, Wang K, Shi Z, Yang H, Dang X, Wang W. Osteogenesis of the construct combined BMSCs with beta-TCP in rat. J Plast Reconstr Aesthet Surg. 2010;63:227–232. doi: 10.1016/j.bjps.2008.11.017. PubMed DOI

Griffin M, Iqbal SA, Bayat A. Exploring the application of mesenchymal stem cells in bone repair and regeneration. J Bone Joint Surg Br. 2011;93:427–434. PubMed

Kim HJ, Park JB, Lee JK, Park EY, Park EA, Riew KD, Rhee SK. Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits. Eur Spine J. 2008;17:1515–1521. doi: 10.1007/s00586-008-0784-9. PubMed DOI PMC

Kim J, Hematti P. Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol. 2009;37:1445–1453. doi: 10.1016/j.exphem.2009.09.004. PubMed DOI PMC

Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D. Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Therapy. 2010;1:2. doi: 10.1186/scrt2. PubMed DOI PMC

Choi HJ, Kim JM, Kwon E, Che JH, Lee JI, Cho SR, Kang SK, Ra JC, Kang BC. Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoral segmental defect model. J Korean Med Sci. 2011;26:482–491. doi: 10.3346/jkms.2011.26.4.482. PubMed DOI PMC

Huang JW, Lin SS, Chen LH, Liu SJ, Niu CC, Yuan LJ, Wu CC, Chen WJ. The use of fluorescence-labeled mesenchymal stem cells in poly(lactide-co-glycolide)/hydroxyapatite/collagen hybrid graft as a bone substitute for posterolateral spinal fusion. J Trauma. 2011;70:1495–1502. doi: 10.1097/TA.0b013e318216b9ee. PubMed DOI

Miura M, Miura Y, Sonoyama W, Yamaza T, Gronthos S, Shi S. Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region. Oral Dis. 2006;12:514–522. doi: 10.1111/j.1601-0825.2006.01300.x. PubMed DOI

Liang H, Wang K, Shimer AL, Li X, Balian G, Shen FH. Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model. Bone. 2010;47:197–204. doi: 10.1016/j.bone.2010.05.023. PubMed DOI

Zhu XS, Zhang ZM, Mao HQ, Geng DC, Zou J, Wang GL, Zhang ZG, Wang JH, Chen L, Yang HL. A novel sheep vertebral bone defect model for injectable bioactive vertebral augmentation materials. J Mater Sci Mater Med. 2011;22:159–164. doi: 10.1007/s10856-010-4191-5. PubMed DOI

Luize DS, Bosco AF, Bonfante S, de Almeida JM. Influence of ovariectomy on healing of autogenous bone block grafts in the mandible: a histomorphometric study in an aged rat model. Int J Oral Maxillofac Implants. 2008;23:207–214. PubMed

Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P. Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy. 2009;11:874–885. doi: 10.3109/14653240903188947. PubMed DOI

Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G. BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci. 2009;29:8884–8896. doi: 10.1523/JNEUROSCI.0968-09.2009. PubMed DOI PMC

Amemori T, Romanyuk N, Jendelova P, Herynek V, Turnovcova K, Prochazka P, Kapcalova M, Cocks G, Price J, Sykova E. Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Therapy. 2013;4:68. doi: 10.1186/scrt219. PubMed DOI PMC

Cocks G, Romanyuk N, Amemori T, Jendelova P, Forostyak O, Jeffries AR, Perfect L, Thuret S, Dayanithi G, Sykova E, Price J. Conditionally immortalized stem cell lines from human spinal cord retain regional identity and generate functional V2a interneurons and motorneurons. Stem Cell Res Therapy. 2013;4:69. doi: 10.1186/scrt220. PubMed DOI PMC

Ruzicka J, Romanyuk N, Hejcl A, Vetrik M, Hruby M, Cocks G, Cihlar J, Pradny M, Price J, Sykova E, Jendelova P. Treating spinal cord injury in rats with a combination of human fetal neural stem cells and hydrogels modified with serotonin. Acta Neurobiol Exp. 2013;73:102–115. PubMed

Jakubek J, Holy T, Jakubek M, Vavrik D, Vykydal Z. Experimental system for high resolution X-ray transmission radiography. Nucl Instr Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip. 2006;563:278–281. doi: 10.1016/j.nima.2006.01.033. DOI

Kytyr D, Jirousek O, Dammer J (2011) High resolution X-ray imaging of bone-implant interface by large area flat-panel detector. J Instrum 6:1–5

Vavrik D, Dammer J, Jakubek J, Jeon I, Jirousek O, Kroupa M, Zlamal P. Advanced X-ray radiography and tomography in several engineering applications. Nucl Instr Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip. 2011;633:S152–S155. doi: 10.1016/j.nima.2010.06.152. DOI

Fujishiro T, Bauer TW, Kobayashi N, Kobayashi H, Sunwoo MH, Seim HB, 3rd, Turner AS. Histological evaluation of an impacted bone graft substitute composed of a combination of mineralized and demineralized allograft in a sheep vertebral bone defect. J Biomed Mater Res A. 2007;82:538–544. PubMed

Kobayashi H, Fujishiro T, Belkoff SM, Kobayashi N, Turner AS, Seim HB, 3rd, Zitelli J, Hawkins M, Bauer TW. Long-term evaluation of a calcium phosphate bone cement with carboxymethyl cellulose in a vertebral defect model. J Biomed Mater Res A. 2009;88:880–888. PubMed

Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006;8:315–317. doi: 10.1080/14653240600855905. PubMed DOI

Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K (2007) Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine (Phila Pa 1976) 32:2432–2436. doi:10.1097/BRS.0b013e3181573924 PubMed

Zerbo IR, Bronckers AL, de Lange G, Burger EH. Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials. 2005;26:1445–1451. doi: 10.1016/j.biomaterials.2004.05.003. PubMed DOI

Boukhechba F, Balaguer T, Bouvet-Gerbettaz S, Michiels JF, Bouler JM, Carle GF, Scimeca JC, Rochet N. Fate of bone marrow stromal cells in a syngenic model of bone formation. Tissue Eng Part A. 2011;17:2267–2278. doi: 10.1089/ten.tea.2010.0461. PubMed DOI

Shapiro F. Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater. 2008;15:53–76. PubMed

Tortelli F, Tasso R, Loiacono F, Cancedda R. The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials. 2010;31:242–249. doi: 10.1016/j.biomaterials.2009.09.038. PubMed DOI

Baraniak PR, McDevitt TC. Stem cell paracrine actions and tissue regeneration. Regen Med. 2010;5:121–143. doi: 10.2217/rme.09.74. PubMed DOI PMC

Nauta AJ, Fibbe WE. Immunomodulatory properties of mesenchymal stromal cells. Blood. 2007;110:3499–3506. doi: 10.1182/blood-2007-02-069716. PubMed DOI

Hoogduijn MJ, Popp F, Verbeek R, Masoodi M, Nicolaou A, Baan C, Dahlke MH. The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol. 2010;10:1496–1500. doi: 10.1016/j.intimp.2010.06.019. PubMed DOI

Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringden O. Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes. Scand J Immunol. 2004;60:307–315. doi: 10.1111/j.0300-9475.2004.01483.x. PubMed DOI

Maccario R, Moretta A, Cometa A, Montagna D, Comoli P, Locatelli F, Podesta M, Frassoni F. Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. Biol Blood Marrow Transpl. 2005;11:1031–1032. doi: 10.1016/j.bbmt.2005.08.039. PubMed DOI

Tcacencu I, Karlstrom E, Cedervall J, Wendel M. Transplanted human bone marrow mesenchymal stem cells seeded onto peptide hydrogel decrease alveolar bone loss. Biores Open Access. 2012;1:215–221. doi: 10.1089/biores.2012.0239. PubMed DOI PMC

Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R. Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther. 2011;6:368–378. doi: 10.2174/157488811797904371. PubMed DOI

The Transplantation of hBM-MSCs Increases Bone Neo-Formation and Preserves Hearing Function in the Treatment of Temporal Bone Defects - on the Experience of Two Month Follow Up

Utilizing Autologous Multipotent Mesenchymal Stromal Cells and β-Tricalcium Phosphate Scaffold in Human Bone Defects: A Prospective, Controlled Feasibility Trial